학술논문
Trial in progress: A phase I/II trial of novel MDM2 inhibitor alrizomadlin (APG-115), with or without platinum chemotherapy, in patients with p53 wild-type salivary gland carcinoma.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755